|
BioPharm
Reports
BioPharm Reports in part of VennBio Ltd and provides services to the pharmaceutical and biotechnology industries. BioPharm Reports researches and evaluates technical and commercial developments in drug R&D and diagnostics, providing information and assessments which companies require for their own operational activities.
Some of our customers:
| Sanofi-Aventis |
Genome Canada |
| Cambridge Antibody Technology |
Oxford BioMedica |
| GlaxoSmithKline |
London Seed Capital |
| Merck |
Aberdeen Asset Management (White Rose) |
| Johnson and Johnson |
Innate Pharmaceuticals AG |
| Medimmune |
Birmingham Research and Development Ltd |
| Ipsen |
Connect Midlands |
| Oncostem Pharma |
National Cancer Institute, US |
| Becton Dickinson |
Eastern Region Biotechnology Initiative |
| Affinium Pharmaceuticals |
University of Nottingham |
| Northern Antibiotics |
Norwich Bio Incubator |
| LSL AG |
Bioclin |
|
